Refreshing results…
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Download from doi.orgThe Exceptional Responders Initiative: Feasibility of A National Cancer Institute Pilot Study
Download from academic.oup.comMissing publications? Search for publications with a matching author name.